AAM
UTHR icon

Augustine Asset Management’s United Therapeutics UTHR Stock Holding History

Augustine Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.36M Buy
9,892
+3,919
+66% +$2.21M 1.09% 19
2026
Q1 		$3.54M Buy
5,973
+39
+0.7% +$19.4K 0.8% 24
2025
Q4 		$2.89M Sell
5,934
-554
-9% -$258K 0.58% 29
2025
Q3 		$2.72M Buy
6,488
+1,206
+23% +$406K 0.55% 27
2025
Q2 		$1.52M Buy
+5,282
New +$1.58M 0.41% 39

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Augustine Asset Management's UTHR Position: Q2 2026 in Review

Augustine Asset Management increased its United Therapeutics (UTHR) stake by 66% in Q2 2026, buying an estimated $2.21M and bringing the position to 9,892 shares worth $5.36M. The position accounts for 1.09% of the portfolio, ranked #19.

Augustine Asset Management first reported a position in UTHR in Q2 2025 and has held it in 5 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Augustine Asset Management held 9,892 shares of United Therapeutics worth $5.36M as of Q2 2026.
  • Augustine Asset Management bought 3,919 United Therapeutics shares in Q2 2026, an estimated $2.21M.
  • United Therapeutics made up 1.09% of Augustine Asset Management's portfolio in Q2 2026, its #19 holding.
  • Augustine Asset Management first reported a position in United Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Augustine Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.